biotech
biotech Articles
The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated:
Shares of Inovio Pharmaceuticals saw a massive gain early on Wednesday after the company announced a critical update from its HIV vaccine.
Published:
Last Updated:
With stocks priced almost to perfection, it may be smart to shift to companies that have better upside potential.
Published:
Last Updated:
After a couple of down years in which the shrill political rhetoric over drug prices kept a pall over the industry, biotech stocks are showing some signs of life.
Published:
Last Updated:
The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) has the potential to make or break companies, with winners walking away from this event with a nice gain and losers trying...
Published:
Last Updated:
AbbVie watched its shares slide on Wednesday following a ruling from the U.S. Patent and Trade Mark Office's Trial and Appeals Board that found in favor of Coherus Biosciences.
Published:
Last Updated:
Athenex has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Pantheon shares saw a huge gain on Monday following the announcement that the company will be acquired by Thermo Fisher Scientific.
Published:
Last Updated:
The WHO has confirmed a new outbreak of the Ebola virus in the Democratic Republic of Congo. A few of the Ebola-related stocks are responding.
Published:
Last Updated:
Ziopharm Oncology saw its shares slide early on Friday after the company announced the pricing of its secondary offering.
Published:
Last Updated:
G1 Therapeutics expects to offer more than 6 million shares in the range of $15 to $17 apiece in an initial public offering valued up to around $122 million.
Published:
Last Updated:
With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it as the industry punching bag.
Published:
Last Updated:
Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.
Published:
Last Updated:
The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated:
The analysts at Stifel have focused on biotech and specialty pharma companies that not only have data that could prove to be huge, but they are offering aggressive accounts the best entry points in...
Published:
Last Updated: